TY  - BOOK
ED  - European Monitoring Center for Drugs and Drug Addiction [EMCDDA]
TI  - ADB-CHMINACA :  Report on the risk assessment of N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA) in the framework of the Council Decision on new psychoactive substances [PDF]

T2  - Risk assessments
PY  - 2018///
CY  - Lisbon
PB  - EMCDDA
KW  - drugs
KW  - Nieuwe Psychoactieve Stoffen
KW  - productinformatie
KW  - onderzoeksrapporten
KW  - risicoschatting
UR  - http://www.google.com/search?q=Report-on-the-risk-assessment-of-N-1-amino-3-3dimethyl-1-oxobutan-2-yl
ER  -